Jump to content

3-Methylbenzylpiperazine

Edit links
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Ira Leviton (talk | contribs) at 14:52, 13 August 2023 (Fixed a reference. Please see Category:CS1 errors: unsupported parameter.). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
3-Methylbenzylpiperazine
Identifiers
  • 1-(3-methylbenzyl)piperazine
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.023.805 Edit this at Wikidata
Chemical and physical data
FormulaC12H18N2
Molar mass190.290 g·mol−1
3D model (JSmol)
  • CC1=CC(=CC=C1)CN2CCNCC2
  • InChI=1S/C12H18N2/c1-11-3-2-4-12(9-11)10-14-7-5-13-6-8-14/h2-4,9,13H,5-8,10H2,1H3
  • Key:VTEOTZPEMDQENX-UHFFFAOYSA-N

3-Methylbenzylpiperazine (3-Me-BZP) is a stimulant drug which is a derivative of benzylpiperazine. It has been sold as a designer drug, first being identified in Sweden in February 2012.[1]

See also

[edit]

References

[edit]
  1. ^ "EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)" (PDF). Lisbon: EMCDDA. May 2013.
Retrieved from "https://en.wikipedia.org/w/index.php?title=3-Methylbenzylpiperazine&oldid=1170174744"